| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18794444 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 104 journal articles in the PubMed database | Email to a friend | | |
| Chu TS, Chen JS, Lopez JP, et al.
Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma. [Journal Article, Research Support, Non-U.S. Gov't]
Arch Otolaryngol Head Neck Surg 2008 Sep; 134(9):979-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lopez JP, Wang-Rodriguez J, Chang C, et al.
Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. [Journal Article, Research Support, Non-U.S. Gov't]
Arch Otolaryngol Head Neck Surg 2007 Oct; 133(10):1022-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Houghton PJ, Germain GS, Harwood FC, et al.
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. [Journal Article]
Cancer Res 2004 Apr 1; 64(7):2333-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nakanishi T, Shiozawa K, Hassel BA, et al.
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression. [Journal Article]
Blood 2006 Jul 15; 108(2):678-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chen JS, Pardo FS, Wang-Rodriguez J, et al.
EGFR regulates the side population in head and neck squamous cell carcinoma. [Journal Article]
Laryngoscope 2006 Mar; 116(3):401-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wang-Rodriguez J, Lopez JP, Altuna X, et al.
STI-571 (Gleevec) Potentiates the Effect of Cisplatin in Inhibiting the Proliferation of Head and Neck Squamous Cell Carcinoma In Vitro. [JOURNAL ARTICLE]
Laryngoscope 2006 Aug; 116(8):1409-1416.
Abstract | Full Citation | Find Related Articles | | Liu W, Baer MR, Bowman MJ, et al.
The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2. [Journal Article]
Clin Cancer Res 2007 Apr 15; 13(8):2463-70.
Abstract | Full Citation | Find Related Articles | | Tsurutani J, West KA, Sayyah J, et al.
Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. [Journal Article]
Cancer Res 2005 Sep 15; 65(18):8423-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Matei D, Chang DD, Jeng MH
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation. [Journal Article]
Clin Cancer Res 2004 Jan 15; 10(2):681-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
